Variation in Genes Controlling Warfarin Disposition and Response in American Indian and Alaska Native People: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX

OBJECTIVES: Pharmacogenetic testing is projected to improve health outcomes and reduce the cost of care by increasing therapeutic efficacy and minimizing drug toxicity. American Indian and Alaska Native (AI/AN) people historically have been excluded from pharmacogenetic research and its potential be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacogenet Genomics
Main Authors: Fohner, Alison E., Robinson, Renee, Yracheta, Joseph, Dillard, Denise A., Schilling, Brian, Khan, Burhan, Hopkins, Scarlett, Boyer, Bert, Black, Jynene, Wiener, Howard, Tiwari, Hemant K., Gordon, Adam, Nickerson, Deborah, Tsai, Jesse M., Farin, Federico M., Thornton, Timothy A., Rettie, Allan E., Thummel, Kenneth E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461509/
https://ncbi.nlm.nih.gov/pubmed/25946405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados